Valuation (74%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 18.89 | N/A |
PEG Ratio (TTM) | 1.14 | N/A |
P/S Ratio (TTM) | 0.80 | N/A |
P/B Ratio (TTM) | 1.10 | N/A |
P/FCF Ratio (TTM) | 22.13 | N/A |
Price to 5YR AVG Earnings Ratio | 8.36 | N/A |
Price to 5YR AVG FCF Ratio | 1,905.92 | N/A |
Profitability (18%) |
Company | Industry |
---|---|---|
ROA (TTM) | 3.25% | N/A |
ROE (TTM) | 5.69% | N/A |
Net Profit Margin (TTM) | 4.21% | N/A |
ROIC 5YR AVG | 1.73% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 144.93% | -182.67% | 378.05% |
Revenue | 1.25% | -5.21% | -4.18% |
Net Income | 115.50% | -178.41% | 362.26% |
Cash Flow | 555.02% | 8,723.87% | 5,129.95% |
Health (74%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.30 | N/A |
Quick Ratio (TTM) | 1.62 | N/A |
D/E Ratio (TTM) | 0.26 | N/A |
Interest Coverage (TTM) | 2.92 | N/A |
Piotroski F-Score | 8 | N/A |
Altman Z-Score | 2.89 | N/A |
LTL to 5YR AVG FCF | 514.84 | N/A |
Shares Outstanding Growth 5YR AVG | -9.45% | N/A |